期刊文献+

血清AFP阴性肝细胞肝癌免疫组化诊断谱研究 被引量:2

Application of immunohistochemical spectrum in diagnosis and differential diagnosis of hepatocellular carcinoma with negative serum AFP
下载PDF
导出
摘要 目的探讨Hep Par1等抗体在诊断血清AFP阴性肝细胞肝癌(HCC)及鉴别肝内胆管细胞癌(ICC)、肝转移性腺癌(MAC)中的意义。方法选取手术切除100例血清AFP阴性HCC、30例ICC及36例MAC(胃腺癌30例、肺腺癌6例)石蜡标本,根据Hep Par1等抗体的染色、表达率、金标准诊断、综合性能计分(CCS)筛选免疫组化诊断谱。结果血清AFP阴性HCC中,Hep Par1胞浆染色(CCS≥8);CD34血管均匀染色(CCS=9);CD10(CCS=8)及CEA毛细胆管染色。ICC、MAC中,CK19(ICC中CCS=7)、CK7(MAC中CCS=7)胞浆染色,CEA膜浆染色。结论诊断血清AFP阴性HCC联用CD34与Hep Par1(或CD10、CEA);鉴别诊断ICC、MAC分别加用CK19、CK7。 Objective To investigate the significance of hepatocyte paraffin-1 (Hep Par-1),cluster of differentiation 34 (CD34),cluster of differentiation 10 (CD10),carcinoembryonic antigen (CEA) and cytokeratin (CK) expression in the diagnosis of hepatocellular carcinoma with negative serum AFP and in the differential diagnosis among AFP (-) HCC,intrahepatic cholangiocellular carcinoma (ICC) and metastatic adenocarcinoma (MAC).Methods Paraffin-embedded surgical specimens were collected from 100 patients with AFP (-) HCC ,30 ICC patients and 36 MAC patients at Nantong Tumor Hospital from 1989 to 2009.All specimens were stained immunohistochemically for Hep Par 1,CD34,CD10,CEA and Cytokeratin,with the stain and expression,the immunohistochemical spectrum was organized according to gold standard and comprehensive capacity score (CCS).Results There were statistically significant differences in the positive expression rates of Hep Par 1,CD34,CD10,CK7 and CK19 in AFP(-) HCC,ICC and MAC (all P0.01).In AFP(-) HCC,Hep Par 1 staining showed uniform brown granular staining in cytoplasm,the CCS was 9 and 8 scores,CD34 staining showed uniform brown twig-like staining in the blood vessels,the CCS was 9 scores.CD10 and CEA staining showed bile duct staining,the CCS of CD10 was 8 scores,the CCS of CEA was 6 and 5 scores.The expression of CK was mostly negative,the CCS of CK20 was 7.In ICC,the expression of Hep Par 1,CD34 and CD10 was mostly negative.CEA showed membranous cytoplasmic staining,CK7 and CK19 showed cytoplasmic granular staining,the CCS of CK19 and CK20 was 7 scores.In MAC,the expression of Hep Par 1 was negative or showed weakly cytoplasmic staining.CEA showed membranous cytoplasmic staining.The expression of CD34,CD10 and CK20 was mostly negative.The expression of CK7,CK20 and CK19 was granular staining in cytoplasm,the CCS was 7 scores.Conclusion The immunohistochemical spectrum in diagnosis and differential diagnosis of AFP (-) HCC was composed as following,Hep Par 1 and CD34 can be used as the firstline antibodies in the initial screening diagnosis of AFP (-) HCC combined with may (or second-line antibody CD10 and CEA),for the further differentiation of ICC,CK19 can be used as the second-line antibody,for the further differentiation of MAC,CK7 can be used as the second-line antibody.
出处 《中国现代医药杂志》 2010年第8期1-5,共5页 Modern Medicine Journal of China
基金 浙江省湖州师范学院校级科研课题(KX30032)
关键词 血清AFP阴性肝细胞肝癌 HEP PAR 1 CD34 CYTOKERATIN CEA Hepatocellular carcinoma with negative serum AFP Hep Par 1 CD34 Cytokeratin CEA
  • 相关文献

参考文献20

  • 1丛文铭,谭璐,张树辉,冼志红,吴伟清,潘晶,张秀忠.肝癌免疫组化诊断谱的研究和应用[J].中华肿瘤杂志,2002,24(6):553-556. 被引量:28
  • 2Wudel LJ, Chapman WC. Indications and limitations of livertrans plantation for hepatocellular carcinoma. Surg Oncol Clin N Am, 2003,12(1):77-90.
  • 3Soresi M, Magliarisi C, Campagna P, et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res, 2003,23(2C): 1747-1753.
  • 4Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol, 1993,143(4): 1050-1054.
  • 5Amarapurkar AD, Rege JD, Joshi AS et al. Utilization of antihepa tocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors. Indian J Pathol Microbiol,2006,49(3):341-344.
  • 6Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol, 2002,26(8):978-988.
  • 7Sutcliffe R, Maguire D, Murphy P, et al. Detection and clinical significance of bone marrow mierometastases in patients undergoing liver transplantation for hepatocellular carcinoma. Transplantation, 2005,15(1):88-94.
  • 8Lau SK, Prakash S, Geller SA, et al. Comparative immunohisto chemical profile of hepatocellular carcinoma, cholangioearcinoma, and metastatic adenocarcinoma. Hum Pathol, 2002, 33 (12):1175 - 1181.
  • 9Minervini MI, Demetris A J, Lee RG, et al. Utilization of hepato cyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol, 1997,10(7):686-692.
  • 10Fan Z, Vande Rijn M, Montgomery K, et al. Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol, 2003,16(2):137-144.

二级参考文献27

  • 1丛文铭,吴孟超.小肝细胞癌的临床病理特点:附93例分析[J].中华肿瘤杂志,1993,15(5):372-374. 被引量:35
  • 2Kakar S,Muir T,Murphy LM, et al.Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma[J].Am J Clin Pathol,2003,119(3):361-366.
  • 3Zimmerman RL,Burke MA,Young NA,et al.Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver[J].Cancer,2001,93(4):288-291.
  • 4Chu PG,Ishizawa S,Wu E, et al.Hepatocyte antigen as a marker of hepatocellular carcinoma:an immunohistochemical comparison to carcinoembryonic antigen,CD10,and alpha-fetoprotein[J].Am J Surg Pathol,2002,26(8):978-988.
  • 5Ohmori S,Shiraki K,Sugimoto K, et al.High expression of CD34 positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases[J].Hum Pathol,2001,32(12):1363-1370.
  • 6Tsuji M,Kashihara T,Terada N, et al.An immunohistochemical study of hepaticatypical adenomatous hyperplasia,hepatocellular carcinoma and cholangiocarcinoma with alpha-fetoprotein,carcinoembryonic antigen,CA 19-9,epithelial membrane antigen, and cytokerati
  • 7Shimonishi T,Miyazaki K,Nakanuma Y.Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver[J].Histopathology,2000,37(1):55-63.
  • 8Leong AS, Sormunen RT,Tsui WM, et al.Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma,combined tumous and metastatic carcinoma[J].Histopathology,1998,33(4):318-324.
  • 9Fasano M, Theise ND,Nalesnik M, et al.Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific-marker,hepatocyte paraffin 1,and the polyclonal anti-carcinoembryonic antigen[J].Mod Pathol,1998,11(10):934-938.
  • 10Lamps LW,Folpe AL.The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors:a review[J].Adv Anat Pathol,2003,10(1):39-43.

共引文献31

同被引文献24

  • 1谢建萍,龚先琼,谭德明,刘菲,周建亮.雌激素受体基因多态性与乙型肝炎肝硬化的相关性研究[J].中南大学学报(医学版),2006,31(3):379-382. 被引量:15
  • 2张晓华,周旭宇.漫谈原发性肝癌的治疗[J].中国普通外科杂志,2006,15(7):484-486. 被引量:9
  • 3刘厚钰原发性肝癌//叶任商,陆再英.内科学6版.北京:人民卫生出版社.2004:450-457.
  • 4丁永康.肝癌的流行因素和预防[J].临床实践医学杂志,2009,8(2):118-120.
  • 5Park DM, Bray F, Ferlay J, et al. Global cancer ststistics, 2002. CA Cancer J Clin, 2005,55 (2) : 74-108.
  • 6Calvisi DF, Ladu S, Gorden A, et al. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest, 2007,117(9) :2713-2722.
  • 7Peter Ferenic, Miechael Fried, Douglas Labrecque, et al. Hepatocellular Carcinomia (HCC): a global perspective. Gastrointestin Liver Dis, 2010, 19 (3) : 311-317.
  • 8Sato H, Nogueira De Souza NC, D Amora P, et al. Intronl and exonl alpha estrogen receptor gene polymorphisms in women with endometriosis. Fertil Steril, 2008,90(6) :2086- 2090.
  • 9Hemdndez J, Balic I, Johnson Pais TL, et al. Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men. J Urol, 2006,175(2) :523-527.
  • 10Yamainot H, Sehoonjans K, Auwerx J. Sirtuin functions in heahh and disease. Mol Endocrinol, 2007,21 (8) : 1745.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部